Mutant PTPN22 in autoimmune mice
Mutant PTPN22 in autoimmune mice
批准号:
9095202
负责人:
LINDA A SHERMAN
金额:
$14.44万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2017-06-30
关键词:
AffectAllelesAmericanAutoimmune DiabetesAutoimmune DiseasesAutoimmune ProcessAutoimmunityBiochemicalCRISPR/Cas technologyCellsCytotoxic T-Lymphocyte-Associated Protein 4DevelopmentDiabetes MellitusDiseaseDisease ProgressionEmbryoExperimental ModelsFemaleFrameshift MutationGenesGeneticGenetic PolymorphismGenetic TranscriptionGerm LinesGerm-Line MutationGoalsHealthHomeostasisHumanImmuneInbred NOD MiceInbreedingIncidenceInfiltrationInsulinInsulin-Dependent Diabetes MellitusLeadLinkLymphocyte FunctionLymphoid CellModelingMusMutateMutationMyeloid CellsNon obeseOrthologous GenePTPN22 genePathway interactionsPhosphoric Monoester HydrolasesPopulationPrevention therapyProtein Tyrosine PhosphataseProteinsPublicationsRelative RisksRheumatoid ArthritisRoleSingle Nucleotide PolymorphismSystemic Lupus ErythematosusSystemic SclerodermaTechnologyTimeVariantbasecell typediabeticdiabetic patientgenetic variantgenome wide association studyimmune functioninnovationinsertion/deletion mutationinsulin dependent diabetes mellitus onsetisletmalemouse modelmutantnovel therapeuticspreventprotein expressiontransmission process
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Autoimmunity is a multigenic disease that generally involves the presence of the pro- autoimmune allele at numerous genetic loci. There is a strong association between a single nucleotide polymorphism (SNP) in the PEST-domain containing intracellular protein tyrosine phosphatase, PTPN22 R620W, and numerous autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, Graves diseases and Type 1 Diabetes. It is not understood how this allele contributes to these diseases. Type 1 diabetes (T1D) is increased in incidence by 2-4 fold when this allele is present. We propose to use the non-obese diabetic (NOD) mouse model of spontaneous type 1 diabetes (T1D) to determine how the mouse orthologue of R620W, R619W, contributes to disease. This model is ideal as many of the genes identified by genome- wide association studies in diabetic patients are the same or on the same pathway as those that contribute to T1D in NOD mice, including MHC, insulin, CTLA-4, and the IL- 2R pathway. The presence of the pro-autoimmune alleles may be critical to assess the impact of the R619W allele on T1D. We have successfully used the Crispr-Cas9 technology to mutate NOD fertilized embryos and produce 2 independent lines of NOD mice that express the R619W variant. We have also obtained several lines that incorporated insertions or deletions (indels) that caused frameshift mutations in this gene. We have ascertained all mutations are germline transmitted, and now propose to determine how they affect PTPN22 expression, immune cell development and homeostasis, and most importantly, disease progression. To this end we will pursue 2 Specific Aims. Aim1 will assess the level of expression of the mutant PTPN22 in various immune cell types from the independently derived NOD murine lines. The primary goal of Aim 2 is to determine whether the R619W and the indel mutants alter the incidence and progression of T1D. We will also assess its effect on immune cell development, function and homeostasis in NOD mice.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2337/db16-0061
发表时间:
2016-08
期刊:
Diabetes
影响因子:
7.7
作者:
[Lin X, Pelletier S, Gingras S, Rigaud S, Maine CJ, Marquardt K, Dai YD, Sauer K, Rodriguez AR, Martin G, Kupriyanov S, Jiang L, Yu L, Green DR, Sherman LA]
通讯作者:
Sherman LA
PTPN22 R619W in NOD mice
-
批准号:10183146
-
项目类别:
-
资助金额:$74.52万
-
财政年份:2017
-
负责人:LINDA A SHERMAN
-
依托单位:
PTPN22 R619W in NOD mice
-
批准号:9307520
-
项目类别:
-
资助金额:$76.27万
-
财政年份:2017
-
负责人:LINDA A SHERMAN
-
依托单位:
Creating Mouse Models to Study the Link Betwee PTPN22 and ACPA+ RA
-
批准号:9300832
-
项目类别:
-
资助金额:$21.18万
-
财政年份:2016
-
负责人:LINDA A SHERMAN
-
依托单位:
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD
-
批准号:7890853
-
项目类别:
-
资助金额:$62.5万
-
财政年份:2009
-
负责人:LINDA A SHERMAN
-
依托单位:
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD
-
批准号:8289098
-
项目类别:
-
资助金额:$83.36万
-
财政年份:2006
-
负责人:LINDA A SHERMAN
-
依托单位:
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD
-
批准号:7134119
-
项目类别:
-
资助金额:$72.98万
-
财政年份:2006
-
负责人:LINDA A SHERMAN
-
依托单位:
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD
-
批准号:7482453
-
项目类别:
-
资助金额:$79.31万
-
财政年份:2006
-
负责人:LINDA A SHERMAN
-
依托单位:
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD
-
批准号:7286038
-
项目类别:
-
资助金额:$77.13万
-
财政年份:2006
-
负责人:LINDA A SHERMAN
-
依托单位:
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD
-
批准号:7676037
-
项目类别:
-
资助金额:$70.32万
-
财政年份:2006
-
负责人:LINDA A SHERMAN
-
依托单位:
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD
-
批准号:8063372
-
项目类别:
-
资助金额:$11.52万
-
财政年份:2006
-
负责人:LINDA A SHERMAN
-
依托单位:
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD
-
批准号:7914037
-
项目类别:
-
资助金额:$83.46万
-
财政年份:2006
-
负责人:LINDA A SHERMAN
-
依托单位:
Core--Transgenic mouse
-
批准号:6589294
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2002
-
负责人:LINDA A SHERMAN
-
依托单位:
Low affinity CD8+ T cells in diabetes
-
批准号:6589292
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2002
-
负责人:LINDA A SHERMAN
-
依托单位:
Low affinity CD8+ T cells in diabetes
-
批准号:6468435
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2001
-
负责人:LINDA A SHERMAN
-
依托单位:
Core--Transgenic mouse
-
批准号:6468437
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2001
-
负责人:LINDA A SHERMAN
-
依托单位:
MODULATION OF EFFECTOR T CELLS IN DIABETES
-
批准号:6381793
-
项目类别:
-
资助金额:$132.81万
-
财政年份:2000
-
负责人:LINDA A SHERMAN
-
依托单位:
MODULATION OF EFFECTOR T CELLS IN DIABETES
-
批准号:6635249
-
项目类别:
-
资助金额:$138.73万
-
财政年份:2000
-
负责人:LINDA A SHERMAN
-
依托单位:
MODULATION OF EFFECTOR T CELLS IN DIABETES
-
批准号:6752415
-
项目类别:
-
资助金额:$138.73万
-
财政年份:2000
-
负责人:LINDA A SHERMAN
-
依托单位:
MODULATION OF EFFECTOR T CELLS IN DIABETES
-
批准号:6087942
-
项目类别:
-
资助金额:$132.81万
-
财政年份:2000
-
负责人:LINDA A SHERMAN
-
依托单位:
Low affinity CD8+ T cells in diabetes
-
批准号:6324881
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2000
-
负责人:LINDA A SHERMAN
-
依托单位:
海外基金